4.5 Article

An inhibitory epitope of human Toll-like receptor 4 resides on leucine-rich repeat 13 and is recognized by a monoclonal antibody

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Immunology

Control of adaptive immunity by the innate immune system

Akiko Iwasaki et al.

NATURE IMMUNOLOGY (2015)

Review Immunology

Multiple roles of toll-like receptor 4 in colorectal cancer

Dhanusha Yesudhas et al.

FRONTIERS IN IMMUNOLOGY (2014)

Article Critical Care Medicine

Immunotherapy for the Adjunctive Treatment of Sepsis: From Immunosuppression to Immunostimulation Time for a Paradigm Change?

Jenneke Leentjens et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Medicine, General & Internal

Effect of Eritoran, an Antagonist of MD2-TLR4, on Mortality in Patients With Severe Sepsis The ACCESS Randomized Trial

Steven M. Opal et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)

Review Immunology

Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy

Richard S. Hotchkiss et al.

NATURE REVIEWS IMMUNOLOGY (2013)

Review Biotechnology & Applied Microbiology

Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists

Francesco Peri et al.

BIOTECHNOLOGY ADVANCES (2012)

Review Pharmacology & Pharmacy

Myeloid differentiation 2 as a therapeutic target of inflammatory disorders

Sun Hong Park et al.

PHARMACOLOGY & THERAPEUTICS (2012)

Review Cardiac & Cardiovascular Systems

Toll like receptor 4 in atherosclerosis and plaque destabilization

Wijnand K. den Dekker et al.

ATHEROSCLEROSIS (2010)

Article Biochemistry & Molecular Biology

Free Thiol Group of MD-2 as the Target for Inhibition of the Lipopolysaccharide-induced Cell Activation

Mateja Mancek-Keber et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Multidisciplinary Sciences

The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex

Beom Seok Park et al.

NATURE (2009)

Article Pharmacology & Pharmacy

Inhibition of endotoxin response by E5564, a novel toll-like receptor 4-directed endotoxin antagonist

M Mullarkey et al.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)